Derivation and representation of dose-volume response from large clinical trial data sets: an example from the RADAR prostate radiotherapy trial

Large multicentre radiotherapy trials incorporating assessment of multiple outcomes at multiple timepoints can generate extensive datasets. We have investigated graphical techniques for presentation of this data and the associated underlying dose-volume response information, necessary for guiding statistical analyses and translating outcomes to future patient treatments. A relational database was used to archive reviewed plan data for patients accrued to the TROG 03.04 RADAR trial. Viewing software was used to clean and enhance the data. Scripts were developed to export arbitrary dose-histogram data which was combined with clinical toxicity data with a median follow-up of 72 months. Graphical representations of dose-volume response developed include prevalence atlasing, univariate logistic regression and dose-volume-point odds ratios, and continuous cut-point derivation via ROC analysis. These representations indicate variable association of toxicities across structures and time-points.

[1]  B. Delahunt,et al.  Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Joseph O Deasy,et al.  The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. , 2010, International journal of radiation oncology, biology, physics.

[3]  M. Sydes,et al.  A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Andrew Jackson,et al.  The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols. , 2006, Seminars in radiation oncology.

[5]  S. S. Young,et al.  Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .

[6]  K. Harrington,et al.  Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  G J Kutcher,et al.  Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. , 2001, International journal of radiation oncology, biology, physics.

[8]  Andrew Jackson,et al.  Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[9]  Youngyih Han,et al.  Development of the DVH management software for the biologically-guided evaluation of radiotherapy plan , 2012, Radiation oncology journal.

[10]  Steve Webb,et al.  Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397) , 2009, Physics in medicine and biology.

[11]  H. Meertens,et al.  Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[12]  N. Spry,et al.  Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  E. Yorke,et al.  Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols. , 2013, International journal of radiation oncology, biology, physics.